LifeMD Inc. | Small-cap | Healthcare
$6.06
-3.50%
| LifeMD Stock Comparison:
LifeMD vs Veeva SystemsLifeMD vs Ge HealthcareLifeMD vs 10x GenomicsLifeMD vs CertaraLifeMD vs OmnicellLifeMD vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 65.7M
Gross Profit 57.1M 86.84%
Operating Income 2.5M 3.87%
Net Income 1.9M 2.92%
EPS (Diluted) $0.01

Balance Sheet Metrics

Total Assets 73.6M
Total Liabilities 74.0M
Shareholders Equity -392.8K

Cash Flow Metrics

Operating Cash Flow 5.5M
Free Cash Flow 201.0K

Revenue & Profitability Trend

LifeMD Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i212.5M152.5M119.0M92.9M37.3M
Cost of Goods Sold i24.1M18.9M18.7M18.0M8.9M
Gross Profit i188.4M133.6M100.4M74.9M28.4M
Gross Margin % i88.7%87.6%84.3%80.6%76.2%
Operating Expenses
Research & Development i9.5M6.1M3.0M948.2K446.7K
Selling, General & Administrative i175.7M128.1M125.3M122.1M84.0M
Other Operating Expenses i19.3M13.9M11.8M6.2M1.8M
Total Operating Expenses i204.5M148.1M140.1M129.2M86.3M
Operating Income i-16.1M-14.5M-39.7M-54.3M-57.8M
Operating Margin % i-7.6%-9.5%-33.3%-58.5%-155.0%
Non-Operating Items
Interest Income i-----
Interest Expense i-----
Other Non-Operating Income--325.2K-3.7M-4.0M-914.9K
Pre-tax Income i-18.3M-17.4M-44.7M-61.3M-60.4M
Income Tax i402.0K428.0K360.7K7.7K122.5K
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-18.7M-17.8M-45.0M-61.3M-60.5M
Net Margin % i-8.8%-11.7%-37.8%-66.0%-162.3%
Key Metrics
EBITDA i-6.7M-7.6M-32.2M-49.4M-56.5M
EPS (Basic) i$-0.53$-0.70$-1.57$-2.29$-4.44
EPS (Diluted) i$-0.53$-0.70$-1.57$-2.29$-4.44
Basic Shares Outstanding i4119629233905155309764552700796114275153
Diluted Shares Outstanding i4119629233905155309764552700796114275153

Income Statement Trend

LifeMD Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i35.0M33.1M4.0M41.3M9.2M
Short-term Investments i-----
Accounts Receivable i8.2M5.3M2.8M980.1K997.8K
Inventory i2.8M2.8M3.7M1.6M1.3M
Other Current Assets2.7M934.5K687.0K793.2K154.9K
Total Current Assets i48.7M42.6M11.3M44.9M12.4M
Non-Current Assets
Property, Plant & Equipment i7.9M476.3K476.4K233.8K274.4K
Goodwill i15.8M14.8M12.7M3.0M715.8K
Intangible Assets i15.8M14.8M12.7M3.0M715.8K
Long-term Investments-----
Other Non-Current Assets-----
Total Non-Current Assets i23.7M15.9M14.4M5.0M990.3K
Total Assets i72.5M58.5M25.7M49.9M13.4M
Liabilities
Current Liabilities
Accounts Payable i16.0M11.1M10.1M9.1M10.4M
Short-term Debt i9.0M930.8K3.6M670.9K872.1K
Current Portion of Long-term Debt-----
Other Current Liabilities-----
Total Current Liabilities i60.3M34.8M31.4M22.8M13.9M
Non-Current Liabilities
Long-term Debt i16.2M18.0M574.1K1.2M192.3K
Deferred Tax Liabilities i----0
Other Non-Current Liabilities100.0K131.2K443.8K100.0K100.0K
Total Non-Current Liabilities i16.3M18.1M1.6M1.3M292.3K
Total Liabilities i76.5M52.9M33.0M24.1M14.2M
Equity
Common Stock i422.9K383.6K315.5K307.0K234.3K
Retained Earnings i-236.3M-214.3M-190.6M-141.9M-80.2M
Treasury Stock i163.7K163.7K163.7K163.7K163.7K
Other Equity-----
Total Shareholders Equity i-4.0M5.6M-7.3M25.8M-821.8K
Key Metrics
Total Debt i25.1M18.9M4.1M1.8M1.1M
Working Capital i-11.5M7.8M-20.1M22.1M-1.5M

Balance Sheet Composition

LifeMD Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-18.7M-17.8M-45.0M-61.3M-60.5M
Depreciation & Amortization i9.5M6.6M3.8M868.8K397.8K
Stock-Based Compensation i12.2M12.5M13.7M12.1M18.7M
Working Capital Changes i4.7M587.2K-315.4K-1.3M-298.0K
Operating Cash Flow i8.9M3.6M-30.9M-47.6M-22.1M
Investing Activities
Capital Expenditures i-1.5M-203.8K-366.6K-247.4K0
Acquisitions i-0-1.0M0-400.0K
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-1.5M-203.8K-1.4M-247.4K-400.0K
Financing Activities
Share Repurchases i-----
Dividends Paid i-3.1M-3.1M-3.1M-871.5K0
Debt Issuance i019.5M015.0M2.6M
Debt Repayment i-327.6K-5.1M-168.8K-16.5M-2.5M
Financing Cash Flow i-4.6M23.9M-825.8K66.0M20.3M
Free Cash Flow i6.0M86.9K-35.8M-36.5M-12.5M
Net Change in Cash i2.8M27.3M-33.1M18.1M-2.2M

Cash Flow Trend

LifeMD Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -11.43
Forward P/E -152.50
Price to Book 703.68
Price to Sales 1.18
PEG Ratio 0.17

Profitability Ratios

Profit Margin -2.41%
Operating Margin -1.46%
Return on Equity 543.53%
Return on Assets -1.85%

Financial Health

Current Ratio 0.77
Debt to Equity 5,767.28
Beta 1.57

Per Share Data

EPS (TTM) $-0.20
Book Value per Share $-0.04
Revenue per Share $5.72

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
lfmd287.3M-11.43703.68543.53%-2.41%5,767.28
Veeva Systems 44.1B55.526.6613.70%27.29%1.29
Ge Healthcare 34.6B14.833.4025.80%11.22%107.67
10x Genomics 1.7B-9.182.18-11.30%-13.13%11.22
Certara 1.7B210.001.580.75%1.97%29.00
Omnicell 1.5B66.901.181.87%2.01%30.42

Financial data is updated regularly. All figures are in the company's reporting currency.